查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1403515

到 2030 年電腦輔助檢測市場預測：按產品類型、適應症、應用、最終用戶和地區進行的全球分析

Computer Aided Detection Market Forecasts to 2030 - Global Analysis By Product Type, Indication, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球電腦輔助偵測市場規模為 8.18 億美元，預計在預測期內將以 7.9% 的複合年成長率成長，到 2030 年達到 13.92 億美元。

電腦輔助檢測 (CAD) 是一組演算法，使用模式識別來幫助醫生解讀醫學影像。電腦輔助檢測軟體透過X光磁振造影、超音波影像、電腦斷層掃描等顯像模式輔助診斷冠狀動脈疾病、癌症、心血管疾病、神經系統疾病等各種疾病。

根據世界衛生組織（WHO）估計，到2022年，癌症將成為全球第一大死因，到2020年將導致約1,000萬人死亡，即幾乎六分之一的人死亡。

對疾病早期檢測的需求不斷成長

早期發現該疾病對於增加成功治療的可能性和改善患者的治療效果至關重要。與診斷成像設備整合的 CAD 系統可幫助放射科醫生透過分析影像並突出顯示潛在的關注區域來及早發現疾病。此外，癌症、心血管疾病和神經系統疾病等慢性疾病的盛行率不斷增加，增加了早期診斷的需求。因此，疾病早期檢測需求的不斷成長成為加速市場需求的關鍵因素。

實施成本高

高實施成本是電腦輔助偵測（CAD）系統進入市場的主要抑制因素。實施 CAD 系統需要大量投資，包括軟體採集費用、硬體基礎設施和醫療保健專業人員培訓成本。 CAD 軟體本身可能很昂貴，特別是如果它是為特定的醫學專業或顯像模式設計的。此外，支援 CAD 系統所需的硬體（例如高效能電腦和儲存解決方案）也會推高整體實施成本。

醫療圖像技術的演變

電腦斷層掃描 (CT)、磁振造影(MRI) 和乳房 X 光攝影等醫療圖像技術的持續進步，為更先進、更詳細的診斷能力鋪平了道路。這些進步不僅提高了醫療圖像的質量，還為 CAD 系統創造了機會，使其能夠更好地檢測細微的異常情況並協助醫療專業人員做出準確的診斷。醫療圖像技術的此類創新將加速市場擴張。

資料隱私

CAD 實施包括處理和儲存敏感的患者資料，例如醫學影像和相關醫療記錄。 CAD 系統分析並解釋這些資訊，引發對潛在違規和詐欺存取的擔憂。維護患者資料的隱私和安全對於遵守醫療保健法規以及建立患者和醫療保健提供者的信任至關重要。因此，資料隱私是一個主要問題並抑制了市場需求。

COVID-19 的影響

大流行期間對醫療保健和診斷的高度關注凸顯了 CAD 等先進技術在疾病檢測和監測方面的重要性。對更準確、更有效率的診斷工具的需求不斷成長，推動了人們對 CAD 解決方案的興趣，以幫助解釋醫學影像，特別是像 COVID-19 這樣的呼吸道疾病。然而，疫情也為CAD市場帶來了挑戰。醫療機構的財務限制和供應鏈中斷正在影響 CAD 系統的實施。

核磁共振成像領域預計將在預測期內成為最大的領域

預計核磁共振成像領域將佔最大佔有率。在電腦輔助檢測中，核磁共振成像在提高影像分析的準確性和效率方面發揮著重要作用。 CAD 系統利用核磁共振成像產生的詳細影像來識別可能表明疾病或狀況存在的潛在異常或可疑模式。此外，NRI 和 CAD 技術的整合提高了檢測率、減少了誤報並提高了整體診斷準確性。

預計腫瘤學在預測期內將經歷最高的複合年成長率。

預計腫瘤學領域在預測期內將出現良好的成長。 CAD 技術透過分析醫療圖像資料幫助醫療保健專業人員早期檢測和表徵癌症病變，從而在腫瘤學中發揮變革性作用。在乳房 X 光檢查、 電腦斷層掃描和 MRI 等模式中，CAD 系統利用先進的演算法來識別細微的異常、潛在的腫瘤以及可能預示徵兆的組織結構不規則性。

比最大的地區

在估計期間，亞太地區佔據最大的市場佔有率。人們越來越認知到早期疾病檢測的好處以及癌症等疾病盛行率的上升，推動了該地區對 CAD 解決方案的需求。亞太地區各國政府正大力投資醫療保健現代化，為 CAD 市場擴張創造有利的環境。此外，在中國和印度等人口眾多、疾病負擔高的國家，CAD 系統因其在提高診斷準確性和效率方面的作用而獲得認可。

複合年成長率最高的地區：

由於穩健的醫療基礎設施和慢性病的高盛行率使 CAD 成為診斷工作流程的關鍵組成部分，預計北美在預測期內將出現盈利成長。尤其美國，由於在研發方面的大量投資、成熟的醫療保健行業以及積極整合最尖端科技的方式，在北美 CAD 市場佔據主導地位。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場公司的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球電腦輔助檢測市場：依產品類型

  • 腹部CAD
  • 攝護腺CAD
  • 乳房電腦輔助設計
  • 心血管CAD
  • 其他產品類型

第6章全球電腦輔助檢測市場：依指標分類

  • 超音波共振成像
  • X光攝影
  • 磁振造影
  • CT檢查
  • 核磁共振成像
  • 乳房X光檢查
  • 其他適應症

第7章全球電腦輔助偵測市場：依應用分類

  • 腫瘤學
    • 大腸直腸癌
    • 乳癌
    • 攝護腺癌
    • 肺癌
    • 骨癌
    • 肝癌
  • 心血管和神經系統癌症

第8章全球電腦輔助檢測市場：依最終用戶分類

  • 診斷中心
  • 醫院
  • 其他最終用戶

第9章全球電腦輔助檢測市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東/非洲

第10章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章 公司簡介

  • Hologic, Inc
  • CANON Medical Systems Corporation
  • EDDA Technology, Inc
  • Koninklijke Philips NV
  • Siemens
  • FUJIFILM Holdings Corporation
  • NANO-X Imaging LTD.
  • General Electric
  • IBM
  • Riverain Technologies
  • iCAD Inc
  • Median Technologies
  • Carestream Health
  • Shimadzu Analytical（India）Pvt. Ltd
  • Karyopharm
Product Code: SMRC24740

According to Stratistics MRC, the Global Computer Aided Detection Market is accounted for $818 million in 2023 and is expected to reach $1392 million by 2030 growing at a CAGR of 7.9% during the forecast period. Computer-aided detection (CAD) is a collection of algorithms that use pattern recognition to help physicians interpret medical images. The computer-aided detection software aids in the diagnosis of various diseases, including coronary artery disease, cancer, cardiovascular diseases, and neurological diseases, through imaging modalities such as x-ray imaging, magnetic resonance imaging, ultrasound imaging, and computed tomography.

According to the World Health Organization (WHO) estimates, in 2022, cancer is the leading cause of death worldwide, resulting in approximately 10 million deaths in 2020, or nearly one in six deaths.

Market Dynamics:

Driver:

Rising demand for early disease detection

Early detection of diseases is crucial, as it enhances the chances of successful treatment and improves patient outcomes. CAD systems integrated with imaging modalities analyze the images and highlight potential areas of concern, aiding radiologists in the early detection of diseases. Moreover, the rising prevalence of chronic diseases such as cancer, cardiovascular diseases, and neurological disorders has heightened the need for early diagnosis. Therefore, growing demand for early disease detection is a significant driver accelerating market demand.

Restraint:

High implementation costs

High implementation costs pose a significant restraint to the adoption of computer-aided detection (CAD) systems on the market. Implementing CAD systems requires substantial investment, which includes the cost of acquiring the software, hardware infrastructure, and training of healthcare professionals. CAD software itself can be expensive, especially if it is designed for specific medical specialties or imaging modalities. Additionally, the hardware requirements to support CAD systems, such as high-performance computers and storage solutions, can add to the overall implementation costs.

Opportunity:

Evolution of medical imaging technologies

The continuous evolution of medical imaging technologies, such as computed tomography (CT), magnetic resonance imaging (MRI), and mammography, has paved the way for more sophisticated and detailed diagnostic capabilities. These advancements not only enhance the quality of medical imaging but also create opportunities for CAD systems to excel in their ability to detect subtle abnormalities and assist healthcare professionals in making accurate diagnoses. These innovations in medical imaging technologies accelerate market expansion.

Threat:

Data privacy

The implementation of CAD involves the processing and storage of sensitive patient data, including medical images and associated health records. As CAD systems analyze and interpret this information, there is a heightened concern for potential breaches and unauthorized access. Maintaining the privacy and security of patient data is crucial to complying with healthcare regulations and building trust among patients and healthcare providers. Therefore, data privacy is a significant concern, hindering market demand.

COVID-19 Impact

The increased focus on healthcare and diagnostics during the pandemic has underscored the importance of advanced technologies like CAD in detecting and monitoring diseases. The demand for more accurate and efficient diagnostic tools has risen, driving interest in CAD solutions that can aid in the interpretation of medical images, especially in the context of respiratory illnesses such as COVID-19. However, the pandemic has also presented challenges for the CAD market. Financial constraints on healthcare facilities, coupled with disruptions in the supply chain, have affected the adoption of CAD systems.

The nuclear resonance imaging segment is expected to be the largest during the forecast period

The nuclear resonance imaging segment is estimated to hold the largest share. In computer-aided detection, nuclear resonance imaging plays a significant role in enhancing the accuracy and efficiency of image analysis. CAD systems utilize the detailed images generated by nuclear resonance imaging to identify potential abnormalities or suspicious patterns that may indicate the presence of a disease or condition. Moreover, the integration of NRI with CAD technology has led to improved detection rates, reduced false positives, and enhanced overall diagnostic accuracy.

The oncology segment is expected to have the highest CAGR during the forecast period

The oncology segment is anticipated to have lucrative growth during the forecast period. CAD technologies play a transformative role in oncology by aiding healthcare professionals in the early detection and characterization of cancerous lesions through the analysis of medical imaging data. In modalities like mammography, CT scans, and MRI, CAD systems utilize advanced algorithms to identify subtle abnormalities, potential tumours, and irregularities in tissue structures that may be indicative of cancer.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period. The demand for CAD solutions in this region is escalating due to increasing awareness of the benefits of early disease detection and a rising prevalence of diseases like cancer. Governments across Asia-Pacific are investing significantly in healthcare modernization, fostering an environment conducive to CAD market expansion. Additionally, in countries like China and India, where large populations contribute to a high disease burden, CAD systems are gaining traction for their role in improving diagnostic accuracy and efficiency.

Region with highest CAGR:

North America is expected to witness profitable growth over the projection period, owing to robust healthcare infrastructure, coupled with a high prevalence of chronic diseases, positions CAD as a crucial component in diagnostic workflows. The United States, in particular, dominates the North American CAD market, owing to substantial investments in research and development, a well-established healthcare sector, and a proactive approach to integrating cutting-edge technologies.

Key players in the market:

Some of the key players in the Computer Aided Detection Market include Hologic Inc, CANON Medical Systems Corporation, EDDA Technology, Inc, Koninklijke Philips N.V, Siemens, FUJIFILM Holdings Corporation, NANO-X Imaging LTD., General Electric, IBM, Riverain Technologies, iCAD Inc, Median Technologies, Carestream Health, Shimadzu Analytical (India) Pvt. Ltd and Karyopharm.

Key Developments:

In October 2023, Hologic, Inc., a global leader in women's health, announced an innovative new partnership with the American Association of Gynecologic Laparoscopists (AAGL) and Inovus Medical.

In October 2023, Hologic, Inc., a global leader in women's health, announced an innovative new partnership with the American Association of Gynecologic Laparoscopists (AAGL) and Inovus Medical. Hologic becomes the chief provider of hystero scopes for AAGL's Essentials in Minimally Invasive Gynecologic Surgery (EMIGS) hands-on hysteroscopy skills training for OB-GYN residents.

Product Types Covered:

  • Abdominal CAD
  • Prostrate CAD
  • Breast CAD
  • Cardiovascular CAD
  • Other Product Types

Indications Covered:

  • Ultrasound Resonance Imaging
  • X-ray Imaging
  • Magnetic Resonance Imaging
  • Computed Tomography
  • Nuclear Resonance Imaging
  • Mammography
  • Other Indications

Applications Covered:

  • Oncology
  • Cardiovascular and Neurological Cancer

End Users Covered:

  • Diagnostic Centers
  • Hospitals
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Computer Aided Detection Market, By Product Type

  • 5.1 Introduction
  • 5.2 Abdominal CAD
  • 5.3 Prostrate CAD
  • 5.4 Breast CAD
  • 5.5 Cardiovascular CAD
  • 5.6 Other Product Types

6 Global Computer Aided Detection Market, By Indication

  • 6.1 Introduction
  • 6.2 Ultrasound Resonance Imaging
  • 6.3 X-ray Imaging
  • 6.4 Magnetic Resonance Imaging
  • 6.5 Computed Tomography
  • 6.6 Nuclear Resonance Imaging
  • 6.7 Mammography
  • 6.8 Other Indications

7 Global Computer Aided Detection Market, By Application

  • 7.1 Introduction
  • 7.2 Oncology
    • 7.2.1 Colorectal Cancer
    • 7.2.2 Breast Cancer
    • 7.2.3 Prostate Cancer
    • 7.2.4 Lung Cancer
    • 7.2.5 Bone Cancer
    • 7.2.6 Liver Cancer
  • 7.3 Cardiovascular and Neurological Cancer

8 Global Computer Aided Detection Market, By End User

  • 8.1 Introduction
  • 8.2 Diagnostic Centers
  • 8.3 Hospitals
  • 8.4 Other End Users

9 Global Computer Aided Detection Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Hologic, Inc
  • 11.2 CANON Medical Systems Corporation
  • 11.3 EDDA Technology, Inc
  • 11.4 Koninklijke Philips N.V
  • 11.5 Siemens
  • 11.6 FUJIFILM Holdings Corporation
  • 11.7 NANO-X Imaging LTD.
  • 11.8 General Electric
  • 11.9 IBM
  • 11.10 Riverain Technologies
  • 11.11 iCAD Inc
  • 11.12 Median Technologies
  • 11.13 Carestream Health
  • 11.14 Shimadzu Analytical (India) Pvt. Ltd
  • 11.15 Karyopharm

List of Tables

  • Table 1 Global Computer Aided Detection Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Computer Aided Detection Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 3 Global Computer Aided Detection Market Outlook, By Abdominal CAD (2021-2030) ($MN)
  • Table 4 Global Computer Aided Detection Market Outlook, By Prostrate CAD (2021-2030) ($MN)
  • Table 5 Global Computer Aided Detection Market Outlook, By Breast CAD (2021-2030) ($MN)
  • Table 6 Global Computer Aided Detection Market Outlook, By Cardiovascular CAD (2021-2030) ($MN)
  • Table 7 Global Computer Aided Detection Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 8 Global Computer Aided Detection Market Outlook, By Indication (2021-2030) ($MN)
  • Table 9 Global Computer Aided Detection Market Outlook, By Ultrasound Resonance Imaging (2021-2030) ($MN)
  • Table 10 Global Computer Aided Detection Market Outlook, By X-ray Imaging (2021-2030) ($MN)
  • Table 11 Global Computer Aided Detection Market Outlook, By Magnetic Resonance Imaging (2021-2030) ($MN)
  • Table 12 Global Computer Aided Detection Market Outlook, By Computed Tomography (2021-2030) ($MN)
  • Table 13 Global Computer Aided Detection Market Outlook, By Nuclear Resonance Imaging (2021-2030) ($MN)
  • Table 14 Global Computer Aided Detection Market Outlook, By Mammography (2021-2030) ($MN)
  • Table 15 Global Computer Aided Detection Market Outlook, By Other Indications (2021-2030) ($MN)
  • Table 16 Global Computer Aided Detection Market Outlook, By Application (2021-2030) ($MN)
  • Table 17 Global Computer Aided Detection Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 18 Global Computer Aided Detection Market Outlook, By Colorectal Cancer (2021-2030) ($MN)
  • Table 19 Global Computer Aided Detection Market Outlook, By Breast Cancer (2021-2030) ($MN)
  • Table 20 Global Computer Aided Detection Market Outlook, By Prostate Cancer (2021-2030) ($MN)
  • Table 21 Global Computer Aided Detection Market Outlook, By Lung Cancer (2021-2030) ($MN)
  • Table 22 Global Computer Aided Detection Market Outlook, By Bone Cancer (2021-2030) ($MN)
  • Table 23 Global Computer Aided Detection Market Outlook, By Liver Cancer (2021-2030) ($MN)
  • Table 24 Global Computer Aided Detection Market Outlook, By Cardiovascular and Neurological Cancer (2021-2030) ($MN)
  • Table 25 Global Computer Aided Detection Market Outlook, By End User (2021-2030) ($MN)
  • Table 26 Global Computer Aided Detection Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 27 Global Computer Aided Detection Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 28 Global Computer Aided Detection Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.